Trade Taysha Gene Therapies Inc - TSHA CFD
What is Taysha Gene Therapies Inc (TSHA)?
Taysha Gene Therapies Inc is a biotechnology company focused on developing gene therapies for central nervous system disorders. The company utilizes adeno-associated virus (AAV) vector technology to create treatments aimed at addressing rare genetic diseases affecting the brain and spinal cord. Its pipeline includes programs targeting conditions such as Rett syndrome, giant axonal neuropathy, and other neurological disorders. Taysha Gene Therapies employs a precision medicine approach, designing therapies tailored to specific genetic mutations. The company engages in research and development activities to advance its clinical candidates through regulatory pathways. It collaborates with scientific and medical communities to enhance understanding and treatment options for rare neurological diseases.
Taysha Gene Therapies Inc Stock Price Today: Live Overview
The price today is shaped by the trading session's flow, with Taysha Gene Therapies Inc now at $4.41. Its price has varied between $4.13 and $4.37, marking a daily change of +1.3953%.
FAQ: Taysha Gene Therapies Inc (TSHA)
What is the current price of TSHA stock?
Taysha Gene Therapies Inc is currently trading at $4.41.
Does TSHA pay dividends?
Taysha Gene Therapies Inc does not pay dividends.
Does TSHA have a formal corporate presence or regional headquarters in the UAE?
Taysha Gene Therapies Inc has no official regional presence in the UAE and operates via partners and distributors.
What is TSHA best known for?
Taysha Gene Therapies Inc is most famous for its work in gene therapy development.
What assets are typically shown together with TSHA?
Commonly shown alongside TSHA: Telecom Italia, European Opportunities Trust, Movado Group Inc
Latest shares articles



